ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NRC vs MXCT // 10Y YIELD & FRED MACRO BETA

NRC Health (NASDAQ) VS. MaxCyte Inc. (NASDAQ) • 15-METRIC TALLY: NRC 10 — MXCT 0
■ METRIC PARITY
macro-sensitivity
—
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NRC VS. MXCT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NRC MXCT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 96.00% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 21.00% -27.10% +48.10 NRC /roic <GO>
EV/EBITDA & P/E Valuation 18.6x — — TIE /valuation <GO>
Free Cash Flow Yield 3.03% -20.26% +23.29 NRC /fcf-yield <GO>
Operating Margin 16.40% -60.00% +76.40 NRC /operating-margins <GO>
Net Profit Margin 8.40% -60.00% +68.40 NRC /net-margins <GO>
Revenue Growth (YoY) -4.00% -5.70% +1.70 NRC /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 2.11% 0.00% +2.11 NRC /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.82 1.52 +2.30 NRC /balance-sheet <GO>
Piotroski F-Score Quality 4/9 3/9 +1.00 NRC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 66.7 65.4 +1.33 NRC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 41.7x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $519.6M $178.5M $341.0M NRC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NRC REV MXCT REV NRC GROSS % MXCT GROSS % NRC FCF MXCT FCF
FY 2025 $137.4M $21.0M — 98.0% $15.7M -$36.2M
FY 2024 $143.1M $22.2M — 98.0% $19.2M -$29.3M
FY 2023 $148.6M $19.5M — — $38.1M -$21.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NRC // BETA —
MXCT // BETA —